Generics 256

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Tranexamic acid manufacturers

256 products found

Filters

256 products found

tranexamic acid

Tablets, film coated 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Estonia , Germany , Iraq , Jordan , Latvia , Libya , Lithuania , Poland , Singapore , Sweden , Syria , United Kingdom , Vietnam
Comments
Ref. CyklokapronRX/OTC
Manufacturer #269

A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

tranexamic acid

Solution for injection 500 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Cyklokapron
Manufacturer #10142
They have more than 40 generic drug products available for license to our global partners. The EU-CTD format is used for all product dossiers. All generic drug products are manufactured in the European Union (EU) and distributed globally to brand partners. Concentrate on delivering high-quality products on time and at a reasonable price.

Manufacturer usually replies in 13 days

Differentiated form - Sachets

tranexamic acid

Sachets 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Italy
Comments
Reference product : Cyklo F® Viatris
Manufacturer #1304

It has dedicated itself to the development of lifecycle products and has created a wide range of technological platforms for oral delivery, with an emphasis on modified-release formulation and oro-dispersible dosage forms. Using these technologies, the company has created a wide range of medicines in a variety of therapeutic areas, including pain, CNS, cardiology, diabetes, gastrointestinal, and others. The company intends to be a global leader in pharmaceuticals, drug delivery, and innovation.

Manufacturer usually replies in 13 days

Want to see all 256 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Tranexamic acid is a coagulation modifier class medication that is used to prevent blood loss after major trauma, factor IX deficiency, hemophilia type A, melasma, nosebleeds, menorrhagia, and menstrual disorders. Manufacturing companies produce it as both standalone medication and in combination drug formulations, along with ingredients such as etamsylate and mefenamic acid. Suppliers market it in the forms of 100mg/ml solution for intravenous injection and 500mg tablets. In use for over 50 years, tranexamic acid is an inexpensive and widely used treatment. The World Health Organisation has included it in its list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Major pharmaceutical manufacturers and supplies of tranexamic acid include Pfizer and Sanofi-Aventis. Tranexamic acid is available in both trade name and generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.